Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma - Notification of holding of treasury shares
Zealand Pharma - Notification of holding of treasury shares
GlobeNewswire

Company announcement – No. 42 / 2026 Zealand Pharma – Notification of holding of treasury shares Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

forbes.com - Dr. Shaheena Janjuha-Jivraj - Why The Next Winners In Beauty Are More Pharma Than Cosmetics
Why The Next Winners In Beauty Are More Pharma Than Cosmetics
Forbes

Demi Moore wins the Best Performance by a Female Actor in a Motion Picture - Musical or Comedy award for 'The Substance' during the 82nd Annual Golden Globes. The film portrays Moore as an aging celebrity who goes to extreme lengths to retain her…

forbes.com - Tim Bajarin - Why AI-Driven Drug Discovery Is Becoming Pharma's Next Big Bet
Why AI-Driven Drug Discovery Is Becoming Pharma's Next Big Bet
Forbes

AI is not replacing scientific intuition but rather enhancing early-stage research. My first two years of college were in a special medical school program focused on the courses required to get into a pharmacy program, to become a pharmacist.

globenewswire.com - TME Pharma NV - TME Pharma provides update on its activities
TME Pharma provides update on its activities
GlobeNewswire

TME Pharma provides update on its activities TME Pharma enters the final evaluation phase of advanced discussions with two potential partners for a license agreement. Discussions and potential partnership are aimed at enabling the further…

japantimes.co.jp - Andrew Silver - Snoring, subways and stealth ads: how big pharma targets China's waistline
Snoring, subways and stealth ads: how big pharma targets China's waistline
The Japan Times

Weight-loss drugmakers, vying to tighten the belts of Chinese consumers, are promoting obesity awareness in metro stations, exercise studios and soccer stadiums as local restrictions prevent the direct advertising of prescription medicines in the…

scmp.com - Vivian Au - Chinese tech, pharma firms eye Hong Kong as springboard for global expansion
Chinese tech, pharma firms eye Hong Kong as springboard for global expansion
South China Morning Post

Mainland Chinese technology and pharmaceutical companies are using Hong Kong as a launching pad for global expansion, industry leaders have said, as a major state-owned drugmaker weighs whether to invest in the city's Northern Metropolis…

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
GlobeNewswire

Company announcement No. 41 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 34, 2026) Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

seekingalpha.com - SA Transcripts - InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call Transcript
InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call Transcript
Seeking Alpha

InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call August 24, 2026 8:30 AM EDT Jisong Cui - Co-Founder, Chairwoman & CEO Xin Fu - Chief Financial Officer Renbin Zhao - Senior VP of Clinical Development & Medical Research and Executive Director…

smh.com.au - Kishor Napier-Raman - Big pharma's next $10 billion gamble: Ozempic for your brain
Big pharma's next $10 billion gamble: Ozempic for your brain
The Sydney Morning Herald

A new wave of treatments for a rare illness are being touted as the next major breakthrough from the same class of drugs as Ozempic, sparking multibillion-dollar acquisitions from pharmaceutical giants but caution from experts who warn that more…

straitstimes.com - How big pharma targets obesity in China's weight-loss market
How big pharma targets obesity in China's weight-loss market
The Straits Times

SHANGHAI – Weight-loss drugmakers, vying to tighten the belts of Chinese consumers, are promoting obesity awareness in metro stations, exercise studios and soccer stadiums as local restrictions prevent the direct advertising of prescription…

thehindubusinessline.com - CBN, PHARMEXCIL sign MoU to boost pharmaceutical exports
CBN, PHARMEXCIL sign MoU to boost pharmaceutical exports
BusinessLine

The Central Bureau of Narcotics (CBN) under the finance ministry and the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), set up by the Ministry of Commerce and Industry, on Monday signed an agreement to boost exports of pharma…

swissinfo.ch - Karoline Arn - US price pressure 'threatens new drugs' in Switzerland
US price pressure 'threatens new drugs' in Switzerland
www.swissinfo.ch

In an interview with Swiss public broadcaster SRF, Buholzer also warns that price pressure from the United States is preventing new drugs from being developed in Switzerland. SRF: Why does such a powerful industry need political support from a…

seekingalpha.com - Galzus Research - Telix Pharmaceuticals: Execution Is The Name Of The Game Here (NASDAQ:TLX)
Telix Pharmaceuticals: Execution Is The Name Of The Game Here (NASDAQ:TLX)
Seeking Alpha

Telix Pharmaceuticals has rebounded strongly, reaching profitability and guiding FY2026 revenue to $950–$970 million, driven by precision medicine sales. Key catalysts include imminent FDA decisions for TLX101-Px (brain tumor imaging) and…

forbes.com - Sally Pipes - Why Hospital Prices Keep Rising-And How Competition Can Help
Why Hospital Prices Keep Rising-And How Competition Can Help
Forbes

“For years, lawmakers in both parties have disproportionately focused on prescription drug prices,” says health expert Sally Pipes. “The latest inflation data suggest it's time to shift that focus.” Prescription drug…

seekingalpha.com - High Alpha Professor - Mortgage REITs Yield Up To 18%: Buy Rithm And Annaly, Avoid Dynex And Armour
Mortgage REITs Yield Up To 18%: Buy Rithm And Annaly, Avoid Dynex And Armour
Seeking Alpha

Rithm Capital offers the best combination of strong dividend coverage (2.4x) and a substantial discount to book value (~0.82x). Annaly Capital earns a Buy rating for its consistent dividend coverage and improving fundamentals, despite trading above…

Receive a Daily briefing on Pharma Industry News

Get Started